Q3 Earnings Alert! Plan early for this week’s stock reports with all key data in 1 placeSee list

Kenvue Inc (KVUE)

NYSE
Currency in USD
Disclaimer
21.32
-0.21(-0.98%)
Closed
After Hours
21.50+0.18(+0.84%)
KVUE Scorecard
Full Analysis
Impressive gross profit margins
Earnings results expected in 13 days
Fair Value
Day's Range
21.2521.60
52 wk Range
17.6723.55
Prev. Close
21.32
Open
21.54
Day's Range
21.25-21.6
52 wk Range
17.67-23.55
Volume
11,911,801
Average Volume (3m)
16,204,940
1-Year Change
8.94%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
KVUE Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
23.70
Upside
+11.16%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory
Show more

InvestingPro Research for Kenvue Inc


Post-Spinoff Dynamics
Explore Kenvue's journey as an independent entity, navigating challenges and opportunities in the competitive consumer health market after its separation from Johnson & Johnson.
Financial Resilience
Discover Kenvue's solid organic sales growth and impressive gross margin expansion, particularly in Essential Health and Self Care divisions, supporting reinvestment plans.
Segment Performance
Delve into the contrasting performances of Kenvue's segments, with Essential Health and Self Care driving growth while Skin Health & Beauty faces challenges and scrutiny.
Future Trajectory
Analyst price targets range from $20 to $25, reflecting cautious optimism about Kenvue's potential for continued momentum and ability to overcome inventory and market challenges.

Kenvue Company Profile

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.

Compare KVUE to Peers and Sector

Metrics to compare
KVUE
Peers
Sector
Relationship
P/E Ratio
36.5x40.3x11.7x
PEG Ratio
−0.81−0.350.03
Price/Book
4.0x3.0x1.5x
Price / LTM Sales
2.6x2.0x0.9x
Upside (Analyst Target)
11.5%60.2%17.2%
Fair Value Upside
Unlock0.6%8.7%Unlock

FAQ

What Is the Kenvue (KVUE) Stock Price Today?

The Kenvue stock price today is 21.32.

What Stock Exchange Does Kenvue Trade On?

Kenvue is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Kenvue?

The stock symbol for Kenvue is "KVUE."

Does Kenvue Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 3.85%.

What Is the Kenvue Market Cap?

As of today, Kenvue market cap is 40.83B.

What is Kenvue Earnings Per Share?

The Kenvue EPS is 0.584.

What Is the Next Kenvue Earnings Date?

Kenvue will release its next earnings report on 23 Oct 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.